Johnson & Johnson at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
Johnson & Johnson brings 11 presentations to SCOPE 2027 in Orlando. Its sessions cover wearable and other digital measures of disease, AI for patient retention and partnerships with sites and health systems. One example uses wearable-derived physiological signals to distinguish treatment response and disease activity in inflammatory bowel disease.
| Organization | SCOPE 2027 Attendance |
|---|---|
Johnson & Johnson New Brunswick, NJ | |
Healthcare company developing and marketing medicines and medical devices; its Innovative Medicine business, formerly Janssen, runs trials worldwide. | Panel Mon Mar 1 4:13pm–4:35pm KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards Patient recruitment and engagement Talk Tue Mar 2 3:05pm–3:30pm Panel Tue Mar 2 4:45pm–5:10pm Panel Tue Mar 2 4:45pm–5:10pm Panel Tue Mar 2 4:45pm–5:10pm Talk Wed Mar 3 9:00am–9:20am Talk Wed Mar 3 9:35am–9:50am Panel Wed Mar 3 12:05pm–12:30pm Talk Wed Mar 3 12:05pm–12:30pm Using Objective Measures of Physical Activity, Sleep, and Breathing for Disease Profiling of Patients with Systemic Lupus Erythematosus and Sjögren’s Disease Digital measures and eClinical technology Panel Wed Mar 3 2:35pm–3:00pm Panel Wed Mar 3 4:12pm–4:42pm KEYNOTE INTERACTIVE PANEL: The Digital Transformation of Clinical Trials: From Protocol to Patient Digital measures and eClinical technologyTrial design and delivery |
Instantly find 20 buyers from Johnson & Johnson
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction